Matthias Dobbelstein

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Venues

The EMBO journal

Proceedings of the National Academy of Sciences of the United States of America

Cancers

EMBO reports

Georg-August-Universität Göttingen Universitätsmedizin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Georg-August-Universität Göttingen Universitätsmedizin

Germany

Director, Professor :: Institute of Molecular Oncology

University of Southern Denmark

Denmark

Professor

Philipps-Universitat Marburg Fachbereich Medizin

Germany

Group leader :: Virology

Princeton University

United States

Postdoctoral Fellow :: Molecular Biology

Publications

Krzysztof Urbanowicz, Mikołaj Opiełka, Kim M Stegmann, Antje Dickmanns, Matthias Dobbelstein, Godefridus J Peters, Ryszard Tomasz Smolenski
Evaluation of N4-hydroxycytidine incorporation into nucleic acids of SARS-CoV-2-infected host cells by direct measurement with liquid chromatography-mass spectrometry. Nucleosides, nucleotides & nucleic acids (2024)
Joshua Blume, Luisa Klemke, Tamara Isermann, Antje Dickmanns, Lena-Christin Conradi, Ramona Schultz-Heddergott, Matthias Dobbelstein
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan. Cell cycle (Georgetown, Tex.) (2023)
Oguz Bolgi, Maria Silva-Garcia, Breyan Ross, Esther Pilla, Vijayalakshmi Kari, Markus Killisch, Melanie Spitzner, Nadine Stark, Christof Lenz, Konstantin Weiss, Laura Donzelli, Mark D Gorrell, Marian Grade, Jan Riemer, Henning Urlaub, Matthias Dobbelstein, Robert Huber, Ruth Geiss-Friedlander
Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair. EMBO reports 23 (10) (2022)
Katharina M Ewers, Shilpa Patil, Waltraut Kopp, Juergen Thomale, Tabea Quilitz, Anna Magerhans, Xin Wang, Elisabeth Hessmann, Matthias Dobbelstein
HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells. Cancers 13 (24) (2021)
Kester Mo Henningsen, Valentina Manzini, Anna Magerhans, Sabrina Gerber, Matthias Dobbelstein
MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters. Biomolecules 12 (1) (2021)
Thomas Güttler, Metin Aksu, Antje Dickmanns, Kim M Stegmann, Kathrin Gregor, Renate Rees, Waltraud Taxer, Oleh Rymarenko, Jürgen Schünemann, Christian Dienemann, Philip Gunkel, Bianka Mussil, Jens Krull, Ulrike Teichmann, Uwe Groß, Volker C Cordes, Matthias Dobbelstein, Dirk Görlich
Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies. The EMBO journal 40 (19) (2021)
Matthias Dobbelstein, Arnold J Levine
Mdm2: Open questions. Cancer science 111 (7) (2020)
Ina Klusmann, Kai Wohlberedt, Anna Magerhans, Federico Teloni, Jan O Korbel, Matthias Altmeyer, Matthias Dobbelstein
Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication. Proceedings of the National Academy of Sciences of the United States of America 115 (48) (2018)

Matthias Dobbelstein

Publication Activity (10 Years)

Top Topics

Top Venues